PROVECTUS Announces Resolution of SEC Investigation – SEC “takes into account the proactive remediation and cooperation by the [C]ompany’s new leadership” – – No monetary penalties; Commission notes actions already taken by Provectus to remedy...

PROVECTUS ANNOUNCES RESULTS FROM MECHANISM OF ACTION STUDY OF TOPICAL PH-10 FOR THE TREATMENT OF PSORIASIS – Responses mediated by multiple pathways, including IL-17, IL-22 and interferons – – Down-regulation of more than 500 disease-related genes; wide range of central “psoriasis-related” genes...